Nasal spray vaccine activates innate immunity for broad protection against pathogens and allergens.
Blood test measuring tau protein levels could predict Alzheimer's onset and timing.
Jim O’Neill nominated as first non-scientist director of the National Science Foundation.
Rising military budgets may constrain global science and shift funding toward AI and national security.
📖 Full Retelling
On February 20, 2026, scientists unveiled a promising "universal" nasal-spray vaccine designed to activate the innate immune system, protecting mice from a diverse range of bacterial, viral, and allergenic threats including SARS-CoV-2. This innovative approach targets the body's innate immunity—a defense mechanism with broader reactivity than the adaptive immune system used by traditional vaccines—offering robust protection for at least three months. If the technology proves safe for human application, it could revolutionize public health strategies by providing a "first line of defense" against seasonal respiratory allergies and future pandemics, potentially administered annually during winter months.
Beyond this immunological breakthrough, the briefing highlighted significant developments in neurodegenerative disease diagnostics. Researchers have developed a blood test measuring abnormal tau protein levels that acts as a "molecular clock," potentially predicting not only whether a patient will develop Alzheimer’s disease but also the timing of its onset. This biomarker could facilitate earlier intervention and significantly reduce the costs and complexity of clinical trials for new treatments.
Furthermore, the geopolitical landscape is influencing the trajectory of global science. With the nomination of biotechnology investor Jim O’Neill to lead the National Science Foundation, the agency will see its first non-scientist director since April 2025. Experts warn that this shift, combined with increased defense budgets among major powers like the United States, China, and NATO members, may prioritize national self-interest over open collaboration. This militarization of science risks sidelining critical fields such as climate research in favor of artificial intelligence and military technologies, reshaping the future of global research funding.
Group of six protein isoforms produced from the MAPT gene
The tau proteins (abbreviated from tubulin associated unit) form a group of six highly soluble protein isoforms produced by alternative splicing from the gene MAPT (microtubule-associated protein tau). They have roles primarily in maintaining the stability of microtubules in axons and are abundant i...
Spray that delivers medications locally in the nasal cavities or systemically
Nasal sprays are used to deliver medications locally in the nasal cavities or systemically. They are used locally for conditions such as nasal congestion and allergic rhinitis. In some situations, the nasal delivery route is preferred for systemic therapy because it provides an agreeable alternative...
The innate immune system or nonspecific immune system is one of the two main immunity strategies in vertebrates (the other being the adaptive immune system). The innate immune system is an alternate defense strategy and is the dominant immune system response found in plants, fungi, prokaryotes, and ...
No entity connections available yet for this article.
Original Source
NATURE BRIEFING 20 February 2026 Daily briefing: ‘Universal’ vaccine protects mice from multiple pathogens A nasal-spray activates the innate immune system to protect against both pathogens and allergens in mice. Plus, how bigger military budgets could change the course of global science and a blood test that could predict the onset of Alzheimer’s disease. By Jacob Smith Jacob Smith View author publications Search author on: PubMed Google Scholar Email Bluesky Facebook LinkedIn Reddit Whatsapp X Sign up for Nature Briefing You have full access to this article via your institution. Hello Nature readers, would you like to get this Briefing in your inbox free every day? Sign up here . Blood test could predict Alzheimer’s onset A simple blood test that measures the levels of an abnormal form of the protein tau' might one day serve as a molecular ‘clock’ that predicts not only whether someone will develop Alzheimer’s disease — but when. If validated in larger studies, the test could provide a way to intervene in the neurodegenerative disease at an earlier stage , when treatment is more likely to be effective. It could also provide a measurable biological marker, or ‘biomarker’, to make clinical trials of potential Alzheimer’s disease treatments easier and cheaper. Nature | 5 min read Reference: Nature Medicine paper Nasal vaccine fends off multiple pathogens A nasal-spray vaccine can provide mice with protection from a variety of bacterial and viral pathogens — including SARS-CoV-2 — and respiratory allergens for at least three months. The vaccine works by revving up the innate immune system , which has a much broader reactivity than does the adaptive immune system — the one conventional vaccines utilize. If the spray proves safe and effective in humans, such a ‘universal vaccine’ could be offered to everyone at the start of each winter — and perhaps provide a first line of defence against future pandemics. Nature | 5 min read Reference: Science paper Biotech investor se...
